Washington, DC 20006-5349
HELPLINE
Adnan Jaigirdar, MD, FACS, provides an overview of the U.S. Food and Drug Administration (FDA) expanded access program (compassionate use) for investigative therapies for mesothelioma patients. Dr. Jaigirdar is…
Five mesothelioma patients — Heather Von St. James, Rich Mosca, Liam Bradley, John Panza and Sara Babin — gathered for a community panel discussion on…
Charles Hesdorffer, MD discussed the immune system and its response to viral infections such as COVID-19, especially as it relates to mesothelioma patients. Dr. Hesdorffer…
Michael Becich, MD, PhD explains the background and purpose of the National Mesothelioma Virtual Tissue Bank (NMVB) — the only national tissue and data repository…
Susan Gillette, LAc led a tutorial on a technique called “tapping” with Katie Jamieson and Heather Von St James, co-chairs of our Community Advisory Board.…
Liz Darlison, head of services at Mesothelioma UK, spoke with Mary Hesdorffer, NP, about mesothelioma treatment in the United Kingdom during COVID-19 and in general. Liz is a…
Anna Nowak, MD, PhD, speaks about immunotherapy and combination of immunotherapy and chemotherapy for mesothelioma patients. She also discusses COVID-19’s effects on mesothelioma in treatment in Australia.…
Buerkley Rose, MSN, RN, discusses how the University of Chicago’s mesothelioma program has adapted during the COVID-19 pandemic: Clinical Trials: Paused. Telemedicine, including psycho-oncology services: Available. Surgery:…
Dr. R. Taylor Ripley discusses his research interests, diet and cancer, as well as seeking care and the mesothelioma program at Baylor College of Medicine during COVID-19: Telemedicine: Available…
Dr. Marjorie G. Zauderer reviews the changes at Memorial Sloan Kettering Cancer Center, located in NYC, during COVID-19: Telemedicine: Available + Dr. Zauderer provides tips for…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
